The Conversation (0)
WeedMD announced a joint agreement with Smart Medicines GMP to increase the market presence of the cannabis company.
WeedMD (TSXV:WMD) announced a joint agreement with Smart Medicines GMP to increase the market presence of the cannabis company.
As quoted in the press release:
Smart Medicines is a leading-edge, research-driven organization that creates, develops and launches pharmaceuticals, natural health products and cosmetics.
“Partnering with a team that understands product development – from ideation to formulation, will provide WeedMD with a significant advantage as we plan for long-term success. I’m pleased to welcome Dr. Domenico Fuoco and the Smart Medicines team, who are already applying their expertise in the development of natural health products, drug development and molecular modeling for a variety of cannabis products,” said Keith Merker, CEO of WeedMD. “Their vision is impressive, and together we’ve laid out an ambitious plan to extend into consumer markets such as health and wellness, cosmetics and nutraceuticals.”
Click here to read the full press release.
Source: globenewswire.com
